Abstract
5-Arylidene-2-oxo-4-thiazolidinones and 2-phenylimino analogues were evaluated for their antidegenerative activity on human chondrocyte cultures stimulated by IL-1β and for their inhibitory capability against matrix metalloproteinase- 13. Our results indicated that 5-arylidene-4-thiazolidinone derivatives 1-9 exhibit antidegenerative activity and could block multiple cartilage destruction during the osteoarthritic process. Out of the selected compounds, (5-arylidene- 2,4-dioxothiazolidin-3-yl)acetic acids 7-9 showed significant effectiveness in reducing NO release and restoring normal levels of GAGs in chondrocytes treated with IL-1β. Moreover, benzoic acids 1, 5 and 6 proved to be effective MMP-13 inhibitors and were able to restore normal levels of GAGs.
Keywords: Antidegenerative activity, Anti-inflammatory activity, 5-Arylidene-2-phenylimino-4-thiazolidinones, 5-Arylidene- 4-thiazolidinones, Glycosaminoglycans, Human chondrocytes, Matrix metalloproteinase-13, Nitric oxide
Medicinal Chemistry
Title:5-Arylidene-4-Thiazolidinone Derivatives Active as Antidegenerative Agents on Human Chondrocyte Cultures
Volume: 9 Issue: 1
Author(s): Annamaria Panico, Rosanna Maccari, Venera Cardile, Lucia Crascì, Simone Ronsisvalle and Rosaria Ottanà
Affiliation:
Keywords: Antidegenerative activity, Anti-inflammatory activity, 5-Arylidene-2-phenylimino-4-thiazolidinones, 5-Arylidene- 4-thiazolidinones, Glycosaminoglycans, Human chondrocytes, Matrix metalloproteinase-13, Nitric oxide
Abstract: 5-Arylidene-2-oxo-4-thiazolidinones and 2-phenylimino analogues were evaluated for their antidegenerative activity on human chondrocyte cultures stimulated by IL-1β and for their inhibitory capability against matrix metalloproteinase- 13. Our results indicated that 5-arylidene-4-thiazolidinone derivatives 1-9 exhibit antidegenerative activity and could block multiple cartilage destruction during the osteoarthritic process. Out of the selected compounds, (5-arylidene- 2,4-dioxothiazolidin-3-yl)acetic acids 7-9 showed significant effectiveness in reducing NO release and restoring normal levels of GAGs in chondrocytes treated with IL-1β. Moreover, benzoic acids 1, 5 and 6 proved to be effective MMP-13 inhibitors and were able to restore normal levels of GAGs.
Export Options
About this article
Cite this article as:
Panico Annamaria, Maccari Rosanna, Cardile Venera, Crascì Lucia, Ronsisvalle Simone and Ottanà Rosaria, 5-Arylidene-4-Thiazolidinone Derivatives Active as Antidegenerative Agents on Human Chondrocyte Cultures, Medicinal Chemistry 2013; 9 (1) . https://dx.doi.org/10.2174/1573406411309010084
DOI https://dx.doi.org/10.2174/1573406411309010084 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Fighting Alzheimer's Disease and Type 2 Diabetes: Pathological links and Treatment Strategies
CNS & Neurological Disorders - Drug Targets Misoprostol for the Treatment of Early Pregnancy Failure
Current Clinical Pharmacology Preface
Current Pharmaceutical Design Iodine in Mammary and Prostate Pathologies
Current Chemical Biology CypD: The Key to the Death Door
CNS & Neurological Disorders - Drug Targets Gene Therapy Targeting Inflammation in Atherosclerosis
Current Pharmaceutical Design Possible Impact of Microglial Cells and the Monocyte-Macrophage System on Suicidal Behavior
CNS & Neurological Disorders - Drug Targets Anticancer Drugs in Liposomal Nanodevices: A Target Delivery for a Targeted Therapy
Current Topics in Medicinal Chemistry Genomics and the Prospects of Existing and Emerging Therapeutics for Cardiovascular Diseases
Current Pharmaceutical Design Inflammatory Fibromyalgia: Is it Real?
Current Rheumatology Reviews Recent Advances in Nanotechnology-Based Drug Delivery Approaches for Alzheimer disease
Current Drug Targets Mitochondrial Dysfunction in Depression
Current Neuropharmacology The Ignored Role of Intraoperative Hypotension in Producing Postoperative Acute Kidney Injury-An Obligatory Appeal for More Preventative Nephrology
Current Hypertension Reviews Equipping CAR-Modified T Cells with a Brake to Prevent Chronic Adverse Effects
Current Gene Therapy Topical Ingenol Mebutate: A New Treatment Modality for Multiple Actinic Keratoses and Field Cancerization
Anti-Cancer Agents in Medicinal Chemistry Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents PCR/SSCP Detects Reliably and Efficiently DNA Sequence Variations in Large Scale Screening Projects
Combinatorial Chemistry & High Throughput Screening Myeloid Derived Suppressor Cells and Their Role in Diseases
Current Medicinal Chemistry Mesenchymal Stem Cells and Their Cell Surface Receptors
Current Rheumatology Reviews Editorial [ Recent Advances in the Biochemistry and Treatment of Cysticercosis Guest Editor: Marta C. Romano ]
Current Topics in Medicinal Chemistry